FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022277129> ?p ?o ?g. }

• W3022277129 abstract "Abstract BACKGROUND: DXA is an accessible, non-invasive method, also used for body composition assessment, standing out for regional composition analysis. In clinical practice, the analysis of body composition is relevant by differentiating lean (fat-free) mass from fat mass. The higher the fat to lean mass ratio, the greater the obesity-related comorbidities. CLINICAL CASE: Case 1: A 22-year-old male, BMI 21kg/m2, with rheumatoid arthritis (RA) and on chronic glucocorticoid (GC) performed a DXA to evaluated body composition. The first analysis, during GC use, showed 26.1% fat (14.6kg) despite the low BMI. The patient, evolved stable from RA, and was able to stay out of GC for 2 years, with no other interventions. A new DXA showed a decrease in fat percentage to 12.6% (6.2kg), a reduction in total body weight (-7kg) and an increase in lean mass (+1.2kg). Within 16 months of GC reintroduction, the fat percentage increased up to 36.8% (23.8kg), the total weight increased by 15.6kg and the lean mass decreased by 2.1kg. Case 2: A 40-year-old male with hypogonadism showed 37% fat (33.8kg) on ​​first DXA evaluation. Testosterone replacement was started, and a new DXA was performed after 10 weeks, and although the total weight increased by 3.1kg, there was a decrease in fat mass to 33.5% (31.6kg) and an increase of 5.3kg in lean mass. After 3 years, there was a reduction to 27.1% of fat (24.5kg) and, after 4 years of therapy initiation, the percentage of fat was 26.9% (24.5kg). There was no change in diet or exercise. CONCLUSION: The exposed cases highlight the importance of body composition assessment in patients with conditions that interferes with energy metabolism. The patient on chronic GC use, after medication withdrawal, presented a significant decrease in fat mass, more pronounced in the android percentage. The reintroduction of the CG showed an increase in fat percentage, with android predominance. The patient with hypogonadism, in the second evaluation performed with only 10 weeks of treatment with testosterone, evolved with a reduction in fat mass associated with an increase in lean mass, besides a reduction in the android percentage. The reported cases illustrate everyday clinical situations in which disease vs. treatment significantly changes body composition. Assessment of body composition is essential in patients exposed to conditions that interfere with energy metabolism since obesity is associated with chronic comorbidities and cardiovascular outcomes." @default.
• W3022277129 created "2020-05-13" @default.
• W3022277129 creator A5041754259 @default.
• W3022277129 creator A5067819779 @default.
• W3022277129 date "2020-04-01" @default.
• W3022277129 modified "2023-09-27" @default.
• W3022277129 title "SUN-650 Body Composition Assessment in Clinical Practice: Use in Rheumatoid Arthritis and Hypogonadism" @default.
• W3022277129 doi "https://doi.org/10.1210/jendso/bvaa046.111" @default.
• W3022277129 hasPublicationYear "2020" @default.
• W3022277129 type Work @default.
• W3022277129 sameAs 3022277129 @default.
• W3022277129 citedByCount "0" @default.
• W3022277129 crossrefType "journal-article" @default.
• W3022277129 hasAuthorship W3022277129A5041754259 @default.
• W3022277129 hasAuthorship W3022277129A5067819779 @default.
• W3022277129 hasBestOaLocation W30222771291 @default.
• W3022277129 hasConcept C111214947 @default.
• W3022277129 hasConcept C120863210 @default.
• W3022277129 hasConcept C126322002 @default.
• W3022277129 hasConcept C134018914 @default.
• W3022277129 hasConcept C138885662 @default.
• W3022277129 hasConcept C147583825 @default.
• W3022277129 hasConcept C2777575956 @default.
• W3022277129 hasConcept C2993503589 @default.
• W3022277129 hasConcept C40231798 @default.
• W3022277129 hasConcept C41895202 @default.
• W3022277129 hasConcept C511355011 @default.
• W3022277129 hasConcept C71924100 @default.
• W3022277129 hasConceptScore W3022277129C111214947 @default.
• W3022277129 hasConceptScore W3022277129C120863210 @default.
• W3022277129 hasConceptScore W3022277129C126322002 @default.
• W3022277129 hasConceptScore W3022277129C134018914 @default.
• W3022277129 hasConceptScore W3022277129C138885662 @default.
• W3022277129 hasConceptScore W3022277129C147583825 @default.
• W3022277129 hasConceptScore W3022277129C2777575956 @default.
• W3022277129 hasConceptScore W3022277129C2993503589 @default.
• W3022277129 hasConceptScore W3022277129C40231798 @default.
• W3022277129 hasConceptScore W3022277129C41895202 @default.
• W3022277129 hasConceptScore W3022277129C511355011 @default.
• W3022277129 hasConceptScore W3022277129C71924100 @default.
• W3022277129 hasLocation W30222771291 @default.
• W3022277129 hasLocation W30222771292 @default.
• W3022277129 hasOpenAccess W3022277129 @default.
• W3022277129 hasPrimaryLocation W30222771291 @default.
• W3022277129 hasRelatedWork W12064005 @default.
• W3022277129 hasRelatedWork W13881678 @default.
• W3022277129 hasRelatedWork W17012617 @default.
• W3022277129 hasRelatedWork W1839243 @default.
• W3022277129 hasRelatedWork W19077061 @default.
• W3022277129 hasRelatedWork W20155150 @default.
• W3022277129 hasRelatedWork W428857 @default.
• W3022277129 hasRelatedWork W466626 @default.
• W3022277129 hasRelatedWork W7819368 @default.
• W3022277129 hasRelatedWork W8012605 @default.
• W3022277129 isParatext "false" @default.
• W3022277129 isRetracted "false" @default.
• W3022277129 magId "3022277129" @default.
• W3022277129 workType "article" @default.